The Super Rich: Start from when the family business is about to go bankrupt!

Chapter 587 WPG Heart Rescue Pills Test Passed, Nova Pharmaceuticals' Production Capacity Proposal, Adhering to the Spirit of the Contract!
Northern Bear Kingdom, Mosk.

Moscow State Hospital.

Originally, CLC Group and Moscow National Hospital recruited fewer than twenty people for the trial treatment of the nitroglycerin.

However, it is unclear who revealed that the drugs being tested by CLC Group and Moscow State Hospital originated from Wugengtian and are primarily used to treat heart-related issues.

As a result, the testing team, which originally consisted of less than twenty people, expanded to over a hundred. More importantly, some testers were not short of money and even paid for testing slots.

At this moment, more than thirty heart patients are staying in a large ward at Moscow State Hospital.

Professor Viktor Konstantinovich Popov and Professor Maria Vladimirovna Mikhailova are discussing something; they are both leading experts in the field of cardiology.

CLC Group's Kashiev is reviewing relevant reports. Although Kashiev doesn't understand medicine, he can read the summary reports.

Sergei was also reviewing the report.

The last time Sergei failed to handle things properly at the pine cone forest, this time Kashiev did not entrust the task of testing the heart medicine to Sergei alone, but personally took Sergei with him to handle it.

Sergei was well aware that Kashiev was balancing his and Vasily's power, but he was powerless to do anything about it.

"Professor Victor, how are your research tests going?" Kashev asked.

Victor responded, "Based on the current situation, we have almost reached the corresponding research conclusions."

Kashev immediately pressed, "What conclusion?"

"The heart-saving pills taken at dawn are very effective for certain heart diseases!" Victor explained.

Maria chimed in, "However, for certain types of heart disease, the nitroglycerin pills taken at dawn are not very effective."

Kashev looked at Maria, "Professor Maria, could you explain the specific classifications in more detail?"

"The 'Five-Watch Heart-Saving Pill' is very effective for angina, arrhythmia, and heart failure," Maria explained.

"But it's not very effective for physical heart damage issues such as myocardial defects and congenital heart disease," Maria added.

“We had hundreds of test subjects, and based on the results of these tests, we obtained these research findings,” Maria summarized.

Kashiev asked, "Have there been any adverse reactions?"

“No,” Maria denied.

Victor also denied this, stating, "None of the more than one hundred test subjects experienced any adverse reactions."

“Some of these patients with severe heart failure showed significant improvement after taking nitroglycerin tablets in an emergency,” Victor added.

Kashiev then asked, "Can the nitroglycerin pills cure the related heart disease?"

"Based on the current experimental data, it should be feasible," Victor explained.

"For example, patients with arrhythmia showed significant improvement after taking the nitroglycerin pills. We expect that with continued use of the nitroglycerin pills, they may be able to recover completely," Victor added.

“But our testing period is still short, and the number of nitroglycerin pills is limited, so it’s unclear how many pills are needed for a full recovery,” Victor continued.

Maria countered, "Mr. Petrov, has the price of these nitroglycerin pills been set?"

“If the price is set, our hospital would like to order some goods,” Maria added.

Maria knew that CLC Group and Wugengtian Pharmaceutical Group were related; otherwise, how could CLC Group have secured Wugengtian's testing project?

Previously, the "Two Joys" test project of Wugengtian was also tested at Moscow National Hospital. Now, they have brought Jiuxinwan (a heart-saving pill) over for testing. The cooperative relationship between CLC Group and Wugengtian is no secret.

Rumors circulate in certain circles of the Northern Bear Kingdom that the illegitimate daughter of the CLC Group's president has a close relationship with the Wugengtian Pharmaceutical Group, which is why the CLC Group is able to establish connections with Wugengtian.

In response to Maria's inquiry, Kashiev sighed and said, "The corresponding price has not yet been announced, and the production capacity is also uncertain. If our CLC can obtain the quota for the heart medicine, your hospital will definitely receive one."

CLC Group and Moscow State Hospital have a very good working relationship; otherwise, why would CLC Group have chosen Moscow State Hospital as the partner hospital to help with testing?

……

Europe.

Nova Pharma launched a larger-scale trial than CLC Group, mainly because the first batch of trials performed very well, so some savvy individuals also chose to pay for the trial.

Nova Pharma's testing is actually more aggressive than that of CL Group and Moscow State Hospital.

Because CLC Group received a limited allocation of nitroglycerin, the testing process could only guarantee that each patient could take one nitroglycerin pill per day.

However, Nova Pharma received a larger quota of nitroglycerin, and they tested it directly at a dosage of three pills per day, so the effect was more obvious.

Both Moscow State Hospital and Nova Pharma have reached the same conclusion: the nitroglycerin pill has limitations and cannot cure all heart diseases.

However, when it comes to curable heart disease, the nitroglycerin pills are incredibly effective. In Japan, they are called "ultra-effective life-saving elixir," which is actually quite accurate.

Xia Dynasty time.

Around noon, An Wuyang received a message from Anna.

Anna: Ms. An, the test results from CLC Group regarding the nitroglycerin pills have arrived. Please review them before dawn.

An Wuyang: Okay, I'll arrange for someone to inspect it right away.

Anna: Aren't you coming to Shanghai this week?

'An Wuyang: Missed me?'

Anna: Mm!

Anna: I miss you!

This foreigner expresses her feelings in such a direct way; she doesn't mince words or try to hide them.

An Wuyang: Then I'll come over this afternoon.

Anna: Okay, I'll take the afternoon off.

Anna: When will you arrive?

'All is well: I'll be leaving shortly.'

'All is well: I expect to arrive around 3 or 4 o'clock.'

Anna: Okay!

Anna: Are you going there today?

The "over there" was, of course, Huashan Apartment. An Wuyang gave a negative answer.

'Peace and safety: I'll stay with you today.'

Anna: That's great!

Anna: I'll wait for you.

'All is well: Okay.'

After finishing his conversation with Anna, An Wuyang directly contacted Melissa, the representative of Nova Pharmaceuticals in Xia Country.

While waiting for the call to be answered, An Wuyang explained that CLC Group had already submitted a test report on the heart-saving pills.

Melissa responded, "Ms. An, I was just about to report on this matter as well. Our Nova team in Europe has almost completed the testing of the nitroglycerin pills."

"The nitroglycerin is outstanding in both safety and therapeutic effect," Melissa praised.

“I will submit the corresponding report to President An immediately,” Melissa added.

An Wuyang refused, saying, "If you submit it directly to the R&D center, how am I supposed to understand it?"

An Wuyang was very self-aware; as an outsider, he wouldn't presume to give unsolicited advice to an expert.

"Now that the testing of the heart-saving pills has been basically completed, I would like to ask what the production capacity of the heart-saving pills can reach?" An Wuyang asked.

Melissa responded, "The specific production capacity depends on the situation of the pharmaceutical company."

“If President An is willing to reallocate some of the production capacity of Shuxin Pills and transfer a portion of the production line to Jiuxin Pills, then there will definitely be no problem with production capacity,” Melissa added.

Seeing that Melissa did not understand what he meant, An Wuyang reminded her, "I'm not talking about the production line."

“Our new and old factory areas have completed intelligent transformation, allowing us to adjust production categories anytime, anywhere,” An Wuyang added.

Now, Wugengtian has completely abandoned its former pharmaceutical business. Both the new and old factory areas have been transformed into intelligent production lines, and the main product now produced is Shuxin Pills.

If we were to change the production line of Shuxinwan (a traditional Chinese medicine) to Jiuxinwan (another traditional Chinese medicine), there would be absolutely no difficulty in doing so.

Melissa responded, "As long as there's a production line to support it, there won't be any problem!"

An Wuyang was speechless. Was that the question he was asking?
An Wuyang could only ask more directly, "Can your Nova Pharmaceuticals procure the other raw materials for the heart-saving pills?"

An Wuyang emphasized the word "others," believing that someone as knowledgeable about Xia Guo as Melissa would understand his meaning.

Melissa finally understood what An Wuyang meant!
Melissa didn't understand before because she didn't think there was anything wrong with the other ingredients in the nitroglycerin pill.

"Please rest assured, Mr. An, our Nova Pharmaceuticals has already established raw material supply channels, and the corresponding raw material supply is guaranteed to be without any problems," Melissa said confidently.

Faced with Melissa's assurance that Nova Pharma could provide raw materials, An Wuyang did not investigate further.

Why delve into it?
Since a world-class pharmaceutical giant like Nova Pharmaceuticals has guaranteed the supply of raw materials, what is there to investigate further?
Should we ask what kind of antelope horn Nova Pharmaceuticals uses to grind its wild antelope horn powder?
The question remains: what kind of deer antler was used in the deer antler powder?
Or, to put it another way, where did Nova Pharmaceuticals get so much natural bezoar?

There's no need to ask these questions in detail!

"President An, our Nova Pharmaceuticals has prepared raw materials for the first batch of two million nitroglycerin pills. Is that alright?" Melissa took the opportunity to suggest the production volume of the first batch of nitroglycerin pills.

Each heart-saving pill requires 1 milligram of vitality restoration factor, so 2 million pills would require 200 kilograms of vitality restoration factor.

Based on experience in extracting vitality-restoring factors before dawn, approximately 30 grams of vitality-restoring factors can be extracted from every kilogram of Morinda officinalis that has reached maturity after five years.
In short, to obtain 2 kilograms of vitality restoration factor, it would require consuming at least a large portion of the Morinda officinalis currently stored on the ground at the Five Watches.

Where can this go?

As for using the freshly planted Morinda officinalis.
Currently, the Morinda officinalis planting area in Wugengtian has only just begun to expand, and the newly planted Morinda officinalis have only been planted for a little over a month. Let alone whether these Morinda officinalis have nurtured vitality-restoring factors.

Even though these Morinda officinalis plants have already developed vitality-restoring factors, they have only just been planted and the yield per acre is very low. How many acres of Morinda officinalis would it take to achieve this?

The vitality-restoring factors contained in Morinda officinalis increase over time.

For example, only 2 grams of vitality restoration factor can be extracted from every kilogram of fresh root of one-year-old Morinda officinalis, but the yield of one-year-old Morinda officinalis per mu is less than 500 kilograms.

In such a case, wouldn't it be a waste to use annual Morinda officinalis to extract vitality-restoring factors?

Therefore, An Wuyang rejected Melissa's proposal without hesitation, "200 million is impossible. Our current stock of Vitality Restoration Factor is already quite low, and it is impossible to provide so much stock to produce a single product."

The so-called "field inventory" actually refers to the Morinda officinalis containing vitality-restoring factors still growing in the soil. When there is demand, it is harvested, extracted, and processed into corresponding products on-site.

"Mr. An, how many nitroglycerin pills do you think we can make in the first batch?" Melissa asked An Wuyang.

Anwuyang should take into account the retail price of Jiuxin Pills.

Previously, when discussing the price of the heart medicine, An Wuyang set the domestic ex-factory price at 5,000 Xia Guoyuan and the overseas ex-factory price at 1,000 US dollars.

In addition, Nova Pharmaceuticals enjoys the most favorable price treatment, with its ex-factory price being 50% of the domestic ex-factory price, which is 2,500 Xia Guoyuan.

The corresponding retail price is 10,000 yuan within China and 3,000 US dollars in overseas markets.

Please note that these prices are for a single pill. The nitroglycerin pills produced in Wugengtian are packaged in PTP packaging, with ten pills per blister pack.

"Let's make 100,000 units for the first batch!" An Wuyang made the decision after considering the terminal price.

Melissa felt somewhat helpless. She thought that if she asked for an exorbitant price, An Wuyang would at least consider producing a little more, but instead, the price was cut from 2 million units to just 5%.

"Mr. An, how about adding some more?" Melissa tentatively suggested.

An Wuyang responded negatively, saying, "Let's see how the market reacts before we comment further."

The task of making money can be left to Shuxinwan; it doesn't necessarily have to be Jiuxinwan that makes a lot of money.

At least not for now!
After all, the production capacity of vitality recovery factors and energy recovery factors is limited at dawn.

"Alright!" Faced with An Wuyang's assertiveness, Melissa had no choice but to agree.

In the collaboration between Nova Pharma and Wugengtian, even though Nova Pharma provided the formula, personnel, and equipment, the final research and development results belonged to Wugengtian, and the production plan was also decided by Wugengtian.

This demonstrates Wugengtian's dominance at the upstream end, leaving no room for challenge from others.

Melissa continued, "President An, can Nova Pharmaceuticals get half of the first batch of nitroglycerin pills?"

This is the cooperation agreement between Nova Pharma and Wugengtian, and it is as stipulated in the agreement, but Melissa still asked questions out of concern.

An Wuyang replied with a smile, "Don't worry, we at Wugengtian abide by the spirit of the contract. What belongs to your Nova Pharmaceuticals, belongs to your Nova Pharmaceuticals. My refusal to agree to your production capacity proposal is only because the current reserves and production of Vitality Restoration Factor are insufficient, not because of Nova Pharmaceuticals."

Melissa breathed a sigh of relief; as long as the spirit of the contract was upheld!
(End of this chapter)